Prognostic criteria for different diseases of prostate

Prognostic criteria for different diseases of prostate

The study involved 263men over 45 years with different diseases of the prostate, including the routine methods and complex immunohistochemical techniques. The use of this complex allows to increase the accuracy of differential diagnosis of the prostate diseases in the primary biopsies and detection...

Full description

Bibliographic Details
Main Authors:	A A Kostin, M I Andriukhin, S A Pul’bere, I I Babichenko, P I Motin, N K Agaev
Format:	Article
Language:	English
Published:	Peoples’ Friendship University of Russia (RUDN University) 2015-12-01
Series:	RUDN Journal of Medicine
Subjects:	рак предстательной железы хронический простатит металлопротеиназы
Online Access:	http://journals.rudn.ru/medicine/article/view/2417

Similar Items

Production of growth factors in benign and malignant prostatic diseases
by: A A Kostin, et al.
Published: (2015-12-01)

Expression of matrix metalloproteinase-9 and protein KI-67 at prostate tumors
by: M I Andrukhin, et al.
Published: (2014-12-01)

Prostate cancer. Principles of early diagnosis
by: A A Kostin, et al.
Published: (2016-12-01)

The role of matrix metalloproteinases and vascular grouth facrors in differentional diagnostic of prostate’s diseases
by: V P Avdoshin, et al.
Published: (2014-12-01)

Prediction of prostate cancer by the general discriminant analysis models
by: A A Kostin, et al.
Published: (2015-12-01)

Prostate biopsy in the outpatient practice
by: P I Talberg, et al.
Published: (2014-12-01)

CD25+CD4+ regulatory т lymphocytes in peripheral blood of patients with prostate cancer and prostate adenoma
by: N M Agaev, et al.
Published: (2010-12-01)

Role of brachytherapy in the treatment of localized prostate cancer
by: A. D. Kaprin, et al.
Published: (2015-01-01)

РОБОТИЗИРОВАННЫЕ СИСТЕМЫ ДЛЯ ПРОВЕДЕНИЯ БРАХИТЕРАПИИ ПРИ РАКЕ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ
Published: (2016-02-01)

Review of the proceedings of the 53rd American Society of Clinical Oncology (ASCO) Annual Meeting
by: R. A. Gafonov
Published: (2017-10-01)

Review of the article “Comparative analysis of adverse events using different methods of prostate biopsy”
by: V. I. Shirokorad, et al.
Published: (2019-04-01)

CONDITION OF THE HEMOSTASIS SYSTEM IN PATIENTS WITH ADENOMA AND PROSTATE CANCER CANCER
by: Ekaterina Victorovna Alymova, et al.
Published: (2019-07-01)

Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
by: M R Lichinitser, et al.
Published: (2009-12-01)

Dynamics and forecast of morbidity and mortality from prostate cancer in St. Petersburg
by: N. G. Petrova, et al.
Published: (2015-09-01)

Оценка качества жизни больных раком предстательной железы после радикальной простатэктомии
by: F. A. Guliev, et al.
Published: (2017-09-01)

Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings)
by: K E Podregul'skiy
Published: (2005-06-01)

Modification of biochemical recurrence risk in patients with localized prostate cancer after radical prostatectomy with combined histomorphological changes in the peritumoral zone
by: F S Bova, et al.
Published: (2018-06-01)

Таксаны как первая и вторая линии химиотерапии метастатического рака предстательной железы
Published: (2019-09-01)

Перспективы популяционного скрининга рака предстательной железы
by: Антон Барчук
Published: (2017-12-01)

Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey
by: P I Rasner, et al.
Published: (2008-12-01)

Review of the article “Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer”
by: K. M. Nussko
Published: (2020-04-01)

Matricsins 2, 7 and 9 in breast tumors. determination of posibile connection with the concentration of HER-2/neu
by: O M Kuznetsova, et al.
Published: (2011-09-01)

The role of prostate-specific antigen in the prediction of hormone-sensitive prostate cancer
by: A. A. Gritskevich, et al.
Published: (2015-12-01)

The frequency of radiation damage in patients with prostate cancer who received the combined treatment after closure of cystostomy
by: S. Д. Sidorova, et al.
Published: (2015-09-01)

Prognostic value of blood flow in prostate in patients with benign prostatic hyperplasia with urine retention
by: E A Atamanova, et al.
Published: (2014-12-01)

Prognostic value of blood flow in prostate in patients with benign prostatic hyperplasia with urine retention
by: E A Atamanova, et al.
Published: (2014-12-01)

Review of the article “ 18F-PSMA-1007 and 18F-fluorocholine PET/CT in prostate cancer progression diagnostics. First comparative experience”
by: O V. Muxortova
Published: (2019-10-01)

Review of the article “An original surgical method for the formation of fascial duplication in the elimination of damage to the anterior rectal wall during prostatectomy”
by: P. A. Karnauh
Published: (2021-05-01)

SINGLE STEP IMPLANTATION OF AN ARTIFICIAL SPHINCTER OF THE BLADDER AND PENILE PROSTHESIS AS A METHOD OF CORRECTING OF ERECTILE DYSFUNCTION AND URINARY INCONTINENCE
by: P. S. Kyzlasov, et al.
Published: (2017-06-01)

Role and significance of multiparametric magnetic resonance imaging in prostate cancer diagnostics
by: Ph. A. Kossov, et al.
Published: (2017-04-01)

Comparison of clinical-economic evaluation of cabazitaxel and abiraterone for prostate cancer based on the results of clinical trials and real world data
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Кабазитаксел во второй линии химиотерапии рака предстательной железы — клинико-экономическая оценка
Published: (2018-06-01)

Medical castration in the treatment of widespread cancers of the prostate. The role of buserelin
by: SV Mishugin, et al.
Published: (2014-12-01)

Prostate blood flow in patients with benign prostatic hyperplasia complicated by urine retention
by: E A Atamanova, et al.
Published: (2012-12-01)

Генетические маркеры предрасположенности к возникновению рака предстательной железы.
Published: (2015-01-01)

КРИПТОСПОРИДИОЗ ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ
Published: (2018-01-01)

An oxide of nitrogen (NO) is a biochemical inflammation marker of chronic abacterial prostatitis/syndrome of chronic pelvic pain (CAP/CPPS IIIA)
by: А V Shangichev
Published: (2010-12-01)

Effective suppression of testosterone: the best castration therapy for hormone-sensitive prostate cancer?
by: A. A. Gritskevich, et al.
Published: (2015-12-01)

The role of Buserelin in the treatment of advanced prostate cancer (APC)
by: S. V. Mishugin, et al.
Published: (2015-12-01)

State of the fermentable antioxidant system of blood, prostate secret and ejaculate at standard treatment of chronic abacterial prostatitis/syndrome of chronic pelvic pain (CAP/CPPS IIIA)
by: А V Shangichev
Published: (2009-03-01)